Opiant Pharmaceuticals Inc - Company & Market Research Reports

Opiant Pharmaceuticals is a specialty pharmaceutical company that develops opioid antagonist treatments for addictions and related disorders. The company’s portfolio includes NARCAN nasal spray, a treatment to reverse opioid overdoses. It is also involved in developing treatments for binge eating disorder and cocaine use disorder, as well as Bulimia Nervosa. Formerly known as Lightlake Therapeutics, it changed its name in January 2016. Opiant Pharmaceuticals, Inc. was founded in 2005 and is headquartered in Santa Monica, California.

From
From
From
From
Drug Overdose - Pipeline Review, H2 2018 - Product Thumbnail Image

Drug Overdose - Pipeline Review, H2 2018

  • Drug Pipelines
  • 65 Pages
From
From
Alcohol Addiction - Pipeline Review, H2 2018 - Product Thumbnail Image

Alcohol Addiction - Pipeline Review, H2 2018

  • Drug Pipelines
  • 151 Pages
From
From
Drug Overdose - Pipeline Review, H1 2018 - Product Thumbnail Image

Drug Overdose - Pipeline Review, H1 2018

  • Drug Pipelines
  • 57 Pages
From
From
From
From
From
From
From
Opiant Pharmaceuticals Inc - Product Thumbnail Image

Opiant Pharmaceuticals Inc

  • Company Profile
  • 74 Pages
  • 19 Results (Page 1 of 1)
Loading Indicator
adroll